Skip to main content
HR 4393 116th Congress House Health Birth defects Cancer Cardiovascular and respiratory health Congressional oversight Digestive and metabolic diseases Genetics Government studies and investigations Health care coverage and access Health care quality Health personnel Health programs administration and funding Health promotion and preventive care Hospital care Medicaid Medical research Medical tests and diagnostic methods Neurological disorders State and local finance State and local government operations

Advancing Access to Precision Medicine Act

Introduced: March 12, 2020 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 19, 2019
Referred to the Subcommittee on Health.
Sep 18, 2019
Referred to the House Committee on Energy and Commerce.
Sep 18, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Advancing Access to Precision Medicine Act

This bill allows state Medicaid programs to cover DNA sequencing clinical services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to a pediatric intensive care unit and seen by a medical specialist for a chronic or undiagnosed disease, and (2) are suspected by a medical specialist to have a pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Additionally, the National Academy of Medicine must study the effects of genetic and genomic testing and ways to expand health insurance coverage of such services, including under Medicare and Medicaid.

What's happening now September 19, 2019

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 3116 Related bill Ending the Diagnostic Odyssey Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 31
All 31 Democratic 21 Republican 1
DAVIS, SUSAN
· Sep 30, 2020
 D
McGovern, James P.
Massachusetts · May 15, 2020
Axne, Cynthia
· Mar 12, 2020
 D
Clarke, Yvette D.
New York · Mar 3, 2020
 D
Khanna, Ro
California · Feb 26, 2020
 D
Dean, Madeleine
Pennsylvania · Feb 21, 2020
Luria, Elaine
· Feb 21, 2020
 D
Veasey, Marc A.
Texas · Feb 21, 2020
 D
Wilson, Frederica S.
Florida · Feb 21, 2020
 D
Bonamici, Suzanne
Oregon · Feb 5, 2020
 D
Kelly, Robin L.
Illinois · Feb 5, 2020
 D
Sewell, Terri A.
Alabama · Feb 5, 2020
Wexton, Jennifer
· Feb 5, 2020
 D
Garamendi, John
California · Feb 4, 2020
McEachin, A.
· Feb 4, 2020
 D
Sherman, Brad
California · Feb 4, 2020
 D
Brownley, Julia
California · Jan 28, 2020
 D
Harder, Josh
California · Jan 28, 2020
 D
Lieu, Ted
California · Jan 28, 2020
Speier, Jackie
· Jan 14, 2020
 D
Watson Coleman, Bonnie
New Jersey · Jan 9, 2020
Butterfield, G. K.
· Jan 8, 2020
 D
Moore, Gwen
Wisconsin · Dec 17, 2019
Brooks, Mo
· Nov 12, 2019
DEFAZIO, PETER
· Nov 12, 2019
 D
Soto, Darren
Florida · Nov 12, 2019
 D
Morelle, Joseph D.
New York · Oct 18, 2019
 D
Raskin, Jamie
Maryland · Oct 11, 2019
 R
Fitzpatrick, Brian K.
Pennsylvania · Sep 18, 2019
 D
Gallego, Ruben
Arizona · Sep 18, 2019
 D
Norton, Eleanor Holmes
District of Columbia · Sep 18, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4393: Advancing Access to Precision Medicine Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4393/
MLA
"H.R. 4393: Advancing Access to Precision Medicine Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4393/.
Bluebook (legal)
H.R. 4393, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4393/.
Markdown link
[H.R. 4393: Advancing Access to Precision Medicine Act](https://openamerica.io/bill/116-HR-4393/)
Report a problem